These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19141678)

  • 1. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A.
    Zhang Y; Schmidt RJ; Foxworthy P; Emkey R; Oler JK; Large TH; Wang H; Su EW; Mosior MK; Eacho PI; Cao G
    Biochem Biophys Res Commun; 2005 Aug; 334(2):729-32. PubMed ID: 16018973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74.
    Mahboubi K; Witman-Jones T; Adamus JE; Letsinger JT; Whitehouse D; Moorman AR; Sawicki D; Bergenhem N; Ross SA
    Biochem Biophys Res Commun; 2006 Feb; 340(2):482-90. PubMed ID: 16389067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
    Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
    J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice.
    Walters RW; Shukla AK; Kovacs JJ; Violin JD; DeWire SM; Lam CM; Chen JR; Muehlbauer MJ; Whalen EJ; Lefkowitz RJ
    J Clin Invest; 2009 May; 119(5):1312-21. PubMed ID: 19349687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A).
    Kostylina G; Simon D; Fey MF; Yousefi S; Simon HU
    Cell Death Differ; 2008 Jan; 15(1):134-42. PubMed ID: 17932499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
    Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A
    Sci Transl Med; 2012 Aug; 4(148):148ra115. PubMed ID: 22914621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acid increases adiponectin secretion from differentiated bovine preadipocytes through G-protein coupled receptor signaling.
    Kopp C; Hosseini A; Singh SP; Regenhard P; Khalilvandi-Behroozyar H; Sauerwein H; Mielenz M
    Int J Mol Sci; 2014 Nov; 15(11):21401-18. PubMed ID: 25411802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids.
    Ge H; Li X; Weiszmann J; Wang P; Baribault H; Chen JL; Tian H; Li Y
    Endocrinology; 2008 Sep; 149(9):4519-26. PubMed ID: 18499755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cells release prostaglandin D2 in response to nicotinic acid.
    Maciejewski-Lenoir D; Richman JG; Hakak Y; Gaidarov I; Behan DP; Connolly DT
    J Invest Dermatol; 2006 Dec; 126(12):2637-46. PubMed ID: 17008871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.
    Semple G; Skinner PJ; Gharbaoui T; Shin YJ; Jung JK; Cherrier MC; Webb PJ; Tamura SY; Boatman PD; Sage CR; Schrader TO; Chen R; Colletti SL; Tata JR; Waters MG; Cheng K; Taggart AK; Cai TQ; Carballo-Jane E; Behan DP; Connolly DT; Richman JG
    J Med Chem; 2008 Aug; 51(16):5101-8. PubMed ID: 18665582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Hydroxybutyric acid inhibits growth hormone-releasing hormone synthesis and secretion through the GPR109A/extracellular signal-regulated 1/2 signalling pathway in the hypothalamus.
    Fu SP; Liu BR; Wang JF; Xue WJ; Liu HM; Zeng YL; Huang BX; Li SN; Lv QK; Wang W; Liu JX
    J Neuroendocrinol; 2015 Mar; 27(3):212-22. PubMed ID: 25580562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
    Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
    Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.
    Boatman PD; Lauring B; Schrader TO; Kasem M; Johnson BR; Skinner P; Jung JK; Xu J; Cherrier MC; Webb PJ; Semple G; Sage CR; Knudsen J; Chen R; Luo WL; Caro L; Cote J; Lai E; Wagner J; Taggart AK; Carballo-Jane E; Hammond M; Colletti SL; Tata JR; Connolly DT; Waters MG; Richman JG
    J Med Chem; 2012 Apr; 55(8):3644-66. PubMed ID: 22435740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
    Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
    Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus.
    Dobbins RL; Shearn SP; Byerly RL; Gao FF; Mahar KM; Napolitano A; Nachbaur GJ; Le Monnier de Gouville AC
    Diabetes Obes Metab; 2013 Nov; 15(11):1013-21. PubMed ID: 23701262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.